Menu
Back to User profile » Dr Pierluigi Benedetti Panici
Papers published by Dr Pierluigi Benedetti Panici:
PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives
Musacchio L, Caruso G, Pisano C, Cecere SC, Di Napoli M, Attademo L, Tambaro R, Russo D, Califano D, Palaia I, Muzii L, Benedetti Panici P, Pignata S
Cancer Management and Research 2020, 12:6123-6135
Published Date: 22 July 2020
First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research
Tomao F, Boccia SM, Sassu CM, Chirra M, Palaia I, Petrella MC, Di Donato V, Colombo N, Benedetti Panici P
Cancer Management and Research 2020, 12:5479-5489
Published Date: 7 July 2020
Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches
Palaia I, Tomao F, Sassu CM, Musacchio L, Benedetti Panici P
OncoTargets and Therapy 2020, 13:6109-6129
Published Date: 26 June 2020
First-line treatment of women with advanced ovarian cancer: focus on bevacizumab
Marchetti C, Muzii L, Romito A, Benedetti Panici P
OncoTargets and Therapy 2019, 12:1095-1103
Published Date: 8 February 2019
Angiogenesis and antiangiogenic agents in cervical cancer
Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S
OncoTargets and Therapy 2014, 7:2237-2248
Published Date: 3 December 2014
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
Marchetti C, Palaia I, Giorgini M, De Medici C, Iadarola R, Vertechy L, Domenici L, Di Donato V, Tomao F, Muzii L, Benedetti Panici P
OncoTargets and Therapy 2014, 7:1223-1236
Published Date: 10 July 2014
Current status of bevacizumab in advanced ovarian cancer
Tomao F, Papa A, Rossi L, Caruso D, Benedetti Panici P, Venezia M, Tomao S
OncoTargets and Therapy 2013, 6:889-899
Published Date: 22 July 2013